DENTSPLY SIRONA (NASDAQ:XRAY) Cut to "Hold" at Wall Street Zen

Wall Street Zen downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a buy rating to a hold rating in a report published on Saturday.

XRAY has been the topic of a number of other reports. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Piper Sandler lowered their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Finally, UBS Group lowered their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Twelve analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Stock Down 0.2%

DENTSPLY SIRONA stock traded down $0.04 during mid-day trading on Friday, hitting $16.54. The company had a trading volume of 1,623,756 shares, compared to its average volume of 2,933,911. The stock has a market cap of $3.30 billion, a price-to-earnings ratio of -3.64, a PEG ratio of 1.19 and a beta of 0.94. DENTSPLY SIRONA has a 1 year low of $12.16 and a 1 year high of $27.95. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The business has a fifty day moving average of $15.70 and a 200 day moving average of $16.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same period last year, the firm posted $0.42 earnings per share. On average, sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.87%. DENTSPLY SIRONA's payout ratio is currently -14.10%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors have recently made changes to their positions in the stock. Treasurer of the State of North Carolina boosted its position in shares of DENTSPLY SIRONA by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after purchasing an additional 560 shares in the last quarter. Quarry LP boosted its position in shares of DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Federated Hermes Inc. boosted its position in shares of DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after purchasing an additional 915 shares in the last quarter. Gabelli Funds LLC boosted its position in shares of DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock worth $1,464,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Covestor Ltd boosted its position in shares of DENTSPLY SIRONA by 14.9% during the 4th quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier's stock worth $158,000 after purchasing an additional 1,081 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.